SurgiMend® vs. Strattice™ in Direct to Implant Breast Reconstruction- A Prospective Randomized Trial

NCT02521623 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Breast Neoplasms

Interventions

DEVICE: SurgiMend® Acellular Dermal Matrix
DEVICE: Strattice™ Acellular Dermal Matrix

Sponsor

Aarhus University Hospital